Skip to main content

Business Models for Pharmacogenetics

Buy Article:

$32.00 plus tax (Refund Policy)

This chapter discusses the challenges posed by pharmacogenetics to established "big pharma" business models in the pharmaceutical and diagnostics and device industries. It considers the viability of current business models and the financial incentives of different types of firms.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Document Type: Review Article

Publication date: 2009-11-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more